MedPath

Diabetes(suger)

Phase 1
Not yet recruiting
Conditions
Type 2 diabetes mellitus without complications,
Registration Number
CTRI/2019/01/017241
Lead Sponsor
Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur
Brief Summary

The drugs of bijakadi yog taken for present study,which is describe as a medicine of premeha in nighantus of dravyaguna in ayurveda .The scientific evaluation of such drugs along with their fundamental principles is essential for their

universal acceptance.Hence in this study an attempt is made to prepare a drug regarding type 2 diabetes.

Through pharmacological and clinical trial in the present study it will be tried to prove the efficacy of the bijakadi yog for  in the management of type 2 diabetes

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria
  • (a) Diagnosed and confirmed cases of Diabetes Mellitus type II, on the basis of the laboratory investigations.
  • (b) Patients between the age group of 18-60 years of either sex.
Exclusion Criteria
  • 1.Patients having Type.
  • DM I [IDDM] 2.Age below 18 and above 60 years. 3.Patient of type II DM who are on Insulin therapy. 4.DM with complications. 5. Uncontrolled DM 8.Drug induced DM. 9.FBS [>250mg/dl] 10. PPBS [>300mg/dl] 11. DM with coronary artery disease.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
efficacy of drug bijkadi yog8 months
To evaluate pharmacological and therapeutic8 months
Secondary Outcome Measures
NameTimeMethod
To evaluate the effect of bijkadi yog on control sugar level in diabetes mellitesone month

Trial Locations

Locations (1)

University Hospital of Ayurveda,Dr.sarvepalli Radhakrishnan Rajasthan Ayurved University

🇮🇳

Jodhpur, RAJASTHAN, India

University Hospital of Ayurveda,Dr.sarvepalli Radhakrishnan Rajasthan Ayurved University
🇮🇳Jodhpur, RAJASTHAN, India
balraj singh rathore
Principal investigator
8949922852
dr.balrajsingh6271@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.